These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7826173)

  • 1. [Use of a new drug, lomefloxacin (maxaquin), from the fluoroquinolone group in the treatment of patients with wound infection].
    Blatun LA; Grishina IA; Svetukhin AM; Iakovlev VP
    Antibiot Khimioter; 1994 Apr; 39(4):37-9. PubMed ID: 7826173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
    Mar'iandyshev AO; Klinberg NM; Shonbina AI; Moroz MI
    Probl Tuberk; 1997; (4):19-21. PubMed ID: 9333808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory assessment of therapeutic efficacy of maxaquin in treatment of chlamydial conjunctivitis].
    Maĭchuk IF; Andzhelov VO; Vakhova ES; Krichevskaia GI
    Vestn Oftalmol; 1997; 113(2):19-21. PubMed ID: 9229897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia].
    Padeĭskaia EN
    Antibiot Khimioter; 2000; 45(1):39-44. PubMed ID: 10690427
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lomefloxacin in phthisiatric practice].
    Grishin VK; Polunina TE
    Antibiot Khimioter; 1998; 43(10):17-8. PubMed ID: 9825104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
    Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
    Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical and microbiological study of the preparation perfloxacin in treating urologic infections].
    Dragiev D; Savov E; Lilov A; Tsenova Z; Saltirov I; Atanasova I
    Khirurgiia (Sofiia); 1993; 46(4):49-51. PubMed ID: 8041098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
    El'kun GB
    Vestn Otorinolaringol; 1999; (6):45-6. PubMed ID: 10596605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of pefloxacin in the treatment of infected burn wounds].
    Iakovlev VP; Alekseev AA; Krutikov MG; Grishina IA; Izotova GN
    Antibiot Khimioter; 1996 Jun; 41(6):39-43. PubMed ID: 9054328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of lomefloxacin in treatment of patients with chronic bronchitis].
    Fedoseev GB; Emel'ianov AV; Rudinskiĭ KA; Shevelev SE; Bykova AV
    Antibiot Khimioter; 1998; 43(10):24-6. PubMed ID: 9825106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of fluoroquinolones in rheumatology].
    Belov BS; Shubin SV; Nasonova VA; Soldatova SI; Tarasova GM; Urumova MM; Ushakova MA; Anan'eva LP
    Vestn Ross Akad Med Nauk; 1996; (12):12-5. PubMed ID: 9102072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
    Neringer R; Forsgren A; Hansson C; Ode B
    Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
    Hoepelman IM; Havinga WH; Benne RA; Zwinkels M; de Wit MA; de Hond HA; Boon TA; Visser MR; van Asbeck FW; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):343-7. PubMed ID: 8394815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 20. Typhoid fevers: treatment with lomefloxacin.
    Hafiz S; Habib F; Ahmad N; Haq I; Husain R
    J Pak Med Assoc; 1998 Jun; 48(6):168-70. PubMed ID: 9813988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.